MedPath

Effect of Office-Based Short-duration High-Impact Exercise on Bone Mineral Density in Healthy Premenopausal Wome

Not Applicable
Conditions
osteoporosis
Registration Number
JPRN-UMIN000000533
Lead Sponsor
Tohoku University Graduate School of Medicine
Brief Summary

inety-one healthy premenopausal women were randomized to receive stretching exercise (SE) or HIE (stretching, along with up to 5 x 10 vertical and versatile jumps) for 12 months. The bone mineral density (BMD) of the lumbar spine and proximal femur was measured using dual-energy X-ray absorptiometry. Several cardiovascular risk factors and leg strength also were assessed. An accelerometer-based recorder was used to measure daily impact loading in four 1-week samples. The progression of the HIE program was ensured by the accelerometer. Thirty-three women (71.7%) in the SE group and 34 (75.6%) in the HIE group completed the study. There was a significant difference in the change in the femoral neck BMD between the groups in favor of the HIE group [0.6% (95% CI: 0.4, 1.7) vs. 1.0% (95% CI: 2.2, 0.2)]. Adiponectin, LDL, HDL, and the leg strength of participants in both the groups improved during the intervention. These finding suggested that office-based brief HIE can be recommended for premenopausal women for preventing bone mineral loss.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

Medication of steroid hormone (corticosteroids, estrogen), Metabolic diseases related to calcium turnover (hyper and hypothyroidism, hyper and hypo-parathyroidism etc) Unable to complete 1 year intervention and examination Pregnant Within 1 year of delivery Within 6 month of breast feeding Ovariectomized Diagnosed as osteoporosis Patients with severe diseases such as cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bone mineral density as assessed by DXA (lumbar spine L1-4, left femoral neck and trochanter), and by QUS(calcaneus)
Secondary Outcome Measures
NameTimeMethod
Bone metabolism marker: cross-linked N. telopetide of type I Collagen(NTX); bone alkaline phosphatase(BAP)
© Copyright 2025. All Rights Reserved by MedPath